Smithbridge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Smithbridge Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32,396	Closed	-$1.88M	–	137
2023 Q3	$1.88M	Sell	32,396 -2,590	-7%	-$159K	0.47%	69
2023 Q2	$2.24M	Sell	34,986 -401	-1%	-$26.9K	0.52%	68
2023 Q1	$2.45M	Buy	35,387 +42	+0.1%	+$2.96K	0.62%	63
2022 Q4	$2.54M	Buy	+35,345	New	+$2.67M	0.68%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Smithbridge Asset Management's BMY Position: Q4 2023 in Review

Smithbridge Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 32,396 shares — an estimated $1.88M sold.

Smithbridge Asset Management first reported a position in BMY in Q4 2022 and held it in 4 quarters. The position peaked at $2.54M in Q4 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Smithbridge Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Smithbridge Asset Management sold 32,396 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.88M.
Smithbridge Asset Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 4 quarters.
Smithbridge Asset Management's Bristol-Myers Squibb position peaked at $2.54M in Q4 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Smithbridge Asset Management's 13F filing for Q4 2023, filed 18 Jan 2024.